Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/ProPhase Labs, Inc./ 10-K

Annual Report · 10-K

ProPhase Labs, Inc.

PRPHOTCEQUITYCurrent

Annual Report

Filed Mar 29, 2024Accepted Mar 28, 2024, 3:27 PM EDTCIK 868278Accession 0000868278-24-000004
View company →Permanent SEC source ↗
Share

Company context

We are a next-generation biotech, genomics and consumer products company. We are also focused on licensing, developing and commercializing novel drugs, dietary supplements, compounds, and diagnostics.

Current securities

PRPHOTC · EQUITY · Current

Recent company filings

  1. 10-Q filingAug 19, 2026
  2. NT 10-Q filingAug 14, 2026
  3. Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet ArrangementAug 6, 2026
  4. 10-Q/A filingJul 9, 2026
  5. 10-Q/A filingJul 7, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗